Annelienke van Hulst

172 Chapter 5 34. Wex H, Ponelis E, Wex T, et al: Plasma leptin and leptin receptor expression in childhood acute lymphoblastic leukemia. Int J Hematol 76:446-52, 2002 35. Izquierdo AG, Crujeiras AB, Casanueva FF, et al: Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later? Nutrients 11, 2019 36. Kuckuck S, van der Valk ES, Scheurink AJW, et al: Glucocorticoids, stress and eating: The mediating role of appetite-regulating hormones. Obes Rev 24:e13539, 2023 37. Touyz LM, Cohen J, Neville KA, et al: Changes in body mass index in long-term survivors of childhood acute lymphoblastic leukemia treated without cranial radiation and with reduced glucocorticoid therapy. Pediatr Blood Cancer 64, 2017 38. Tonorezos ES, Vega GL, Sklar CA, et al: Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatr Blood Cancer 58:31-6, 2012 39. Jahnukainen K, Heikkinen R, Henriksson M, et al: Increased Body Adiposity and Serum Leptin Concentrations in Very Long-Term Adult Male Survivors of Childhood Acute Lymphoblastic Leukemia. Horm Res Paediatr 84:108-15, 2015 40. Eisenkolbl J, Kartasurya M, Widhalm K: Underestimation of percentage fat mass measured by bioelectrical impedance analysis compared to dual energy X-ray absorptiometry method in obese children. Eur J Clin Nutr 55:423-9, 2001 41. Orgel E, Mueske NM, Sposto R, et al: Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapy. Leuk Lymphoma 59:138145, 2018 42. Ghaben AL, Scherer PE: Adipogenesis and metabolic health. Nat Rev Mol Cell Biol 20:242258, 2019 43. Wardle J, Guthrie CA, Sanderson S, et al: Development of the Children’s Eating Behaviour Questionnaire. J Child Psychol Psychiatry 42:963-70, 2001 44. Daniel LC, Li Y, Kloss JD, et al: The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia. Support Care Cancer 24:3897-906, 2016 45. Hinds PS, Hockenberry MJ, Gattuso JS, et al: Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer 110:2321-30, 2007 46. Rosen G, Harris AK, Liu M, et al: The effects of dexamethasone on sleep in young children with acute lymphoblastic leukemia. Sleep Med 16:503-9, 2015 47. Sanford SD, Okuma JO, Pan J, et al: Gender differences in sleep, fatigue, and daytime activity in a pediatric oncology sample receiving dexamethasone. J Pediatr Psychol 33:298-306, 2008 48. Hart CN, Carskadon MA, Considine RV, et al: Changes in children’s sleep duration on food intake, weight, and leptin. Pediatrics 132:e1473-80, 2013 49. Piche T, Gelsi E, Schneider SM, et al: Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut 51:434-9, 2002 50. Piche T, Huet PM, Gelsi E, et al: Fatigue in irritable bowel syndrome: characterization and putative role of leptin. Eur J Gastroenterol Hepatol 19:237-43, 2007 51. Stringer EA, Baker KS, Carroll IR, et al: Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology. J Transl Med 11:93, 2013 52. Kiernan K, MacIver NJ: The Role of the Adipokine Leptin in Immune Cell Function in Health and Disease. Front Immunol 11:622468, 2020 53. Yang L, Panetta JC, Cai X, et al: Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. J Clin Oncol 26:1932-9, 2008

RkJQdWJsaXNoZXIy MTk4NDMw